{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T07:12:57Z","timestamp":1772089977911,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tunisian Ministry of Higher Education and Research","award":["LR19CBS02"],"award-info":[{"award-number":["LR19CBS02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11598-0","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:27:15Z","timestamp":1772087235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unexpected double-hit BRCA1\/BRCA2 somatic mutations in a sporadic endometrioid ovarian carcinoma"],"prefix":"10.1007","volume":"53","author":[{"given":"Nihel","family":"Ammous-Boukhris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"Abdelmaksoud-Dammak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameni","family":"Feki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wala Ben","family":"kridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afef","family":"Khanfir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Gargouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Mokdad-Gargouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"3","key":"11598_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"11598_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1055\/a-1545-4279","volume":"81","author":"AK H\u00f6hn","year":"2021","unstructured":"H\u00f6hn AK et al (2021) 2020 WHO Classification of Female Genital Tumors. Geburtshilfe Frauenheilkd 81(10):1145\u20131153","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"3","key":"11598_CR3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","volume":"20","author":"KP Pennington","year":"2014","unstructured":"Pennington KP et al (2014) Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res 20(3):764\u2013775","journal-title":"Clin Cancer Res"},{"issue":"11","key":"11598_CR4","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1200\/JCO.19.02960","volume":"38","author":"PA Konstantinopoulos","year":"2020","unstructured":"Konstantinopoulos PA et al (2020) Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline. J Clin Oncol 38(11):1222\u20131245","journal-title":"J Clin Oncol"},{"key":"11598_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fonc.2018.00016","volume":"8","author":"S Mylavarapu","year":"2018","unstructured":"Mylavarapu S, Das A, Roy M (2018) Role of BRCA Mutations in the Modulation of Response to Platinum Therapy. Front Oncol 8:16","journal-title":"Front Oncol"},{"issue":"9","key":"11598_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.trecan.2024.06.008","volume":"10","author":"D Dibitetto","year":"2024","unstructured":"Dibitetto D, Widmer CA, Rottenberg S (2024) PARPi, BRCA, and gaps: controversies and future research. Trends Cancer 10(9):857\u2013869","journal-title":"Trends Cancer"},{"key":"11598_CR7","doi-asserted-by":"crossref","unstructured":"Faraoni I, Graziani G (2018) Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors. Cancers 10(12) :487","DOI":"10.3390\/cancers10120487"},{"key":"11598_CR8","doi-asserted-by":"crossref","unstructured":"Wakaki N et al (2025) Double heterozygosity for BRCA1 and BRCA2 in breast cancer: considerations in surveillance and cancer risk management. BMJ Case Rep 18(4) :e263687","DOI":"10.1136\/bcr-2024-263687"},{"key":"11598_CR9","doi-asserted-by":"crossref","unstructured":"Hamdi Y et al (2021) Identification of BRCA2 Cis Double Heterozygous Breast Cancer Cases Using Whole Exome Sequencing: Phenotypic Expression and Impact on Personalized Oncology. Front Genet 12 :674990","DOI":"10.3389\/fgene.2021.674990"},{"issue":"3","key":"11598_CR10","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10549-012-2050-4","volume":"134","author":"S Heidemann","year":"2012","unstructured":"Heidemann S et al (2012) Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management. Breast Cancer Res Treat 134(3):1229\u20131239","journal-title":"Breast Cancer Res Treat"},{"issue":"20","key":"11598_CR11","doi-asserted-by":"publisher","first-page":"15334","DOI":"10.3390\/ijms242015334","volume":"24","author":"L Madar","year":"2023","unstructured":"Madar L et al (2023) Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer. Int J Mol Sci 24(20):15334","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11598_CR12","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3892\/or.2017.5422","volume":"37","author":"G Meynard","year":"2017","unstructured":"Meynard G et al (2017) First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report. Oncol Rep 37(3):1573\u20131578","journal-title":"Oncol Rep"},{"key":"11598_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejca.2016.03.005","volume":"60","author":"JA Ledermann","year":"2016","unstructured":"Ledermann JA, Drew Y, Kristeleit RS (2016) Homologous recombination deficiency and ovarian cancer. Eur J Cancer 60:49\u201358","journal-title":"Eur J Cancer"},{"key":"11598_CR14","doi-asserted-by":"crossref","unstructured":"Toss A et al (2021) The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study. Diagnostics 11(3) :565","DOI":"10.3390\/diagnostics11030565"},{"issue":"2","key":"11598_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nrm2831","volume":"11","author":"MS Huen","year":"2010","unstructured":"Huen MS, Sy SM, Chen J (2010) BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 11(2):138\u2013148","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"11598_CR16","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s10549-012-2159-5","volume":"134","author":"H Kim","year":"2012","unstructured":"Kim H et al (2012) Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer. Breast Cancer Res Treat 134(3):1315\u20131326","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"11598_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4048\/jbc.2013.16.4.357","volume":"16","author":"H Kim","year":"2013","unstructured":"Kim H, Choi DH (2013) Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer. J Breast Cancer 16(4):357\u2013365","journal-title":"J Breast Cancer"},{"key":"11598_CR18","doi-asserted-by":"publisher","first-page":"1030786","DOI":"10.3389\/fonc.2022.1030786","volume":"12","author":"A Andrikopoulou","year":"2022","unstructured":"Andrikopoulou A et al (2022) Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis. Front Oncol 12:1030786","journal-title":"Front Oncol"},{"issue":"4","key":"11598_CR19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ajhg.2022.01.019","volume":"109","author":"AI Adamovich","year":"2022","unstructured":"Adamovich AI et al (2022) The functional impact of BRCA1 BRCT domain variants using multiplexed DNA double-strand break repair assays. Am J Hum Genet 109(4):618\u2013630","journal-title":"Am J Hum Genet"},{"key":"11598_CR20","doi-asserted-by":"crossref","unstructured":"Ismail T et al (2024) BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer. Pharmaceuticals 17(3) :333","DOI":"10.3390\/ph17030333"},{"issue":"8050","key":"11598_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41586-024-08388-8","volume":"638","author":"H Huang","year":"2025","unstructured":"Huang H et al (2025) Functional evaluation and clinical classification of BRCA2 variants. Nature 638(8050):528\u2013537","journal-title":"Nature"},{"issue":"5","key":"11598_CR22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jmb.2009.09.011","volume":"393","author":"A Tal","year":"2009","unstructured":"Tal A, Arbel-Goren R, Stavans J (2009) Cancer-Associated Mutations in BRC Domains of BRCA2 Affect Homologous Recombination Induced by Rad51. J Mol Biol 393(5):1007\u20131012","journal-title":"J Mol Biol"},{"issue":"5","key":"11598_CR23","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1292\/jvms.21-0006","volume":"83","author":"Y Yoshikawa","year":"2021","unstructured":"Yoshikawa Y et al (2021) Identification of the core motif of the BRCA2 C-terminal RAD51-binding domain by comparing canine and human BRCA2. J Vet Med Sci 83(5):759\u2013766","journal-title":"J Vet Med Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11598-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11598-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11598-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:27:17Z","timestamp":1772087237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11598-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11598"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11598-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from The Faculty of Medicine of Sfax, Tunisia (CPP SUD N\u00b0177\/2024), and written informed consent was obtained from all participants prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"430"}}